GLP-1 agonist treatment: Implications for diabetic retinopathy screening

Diabetes Research and Clinical Practice

Volumn 94, Issue 3, 2011, Pages

  Varadhan, Lakshminarayanan ^a   Humphreys, Tracy ^a   Hariman, Christian ^a   Walker, Adrian B ^a   Varughese, George I ^a  

^a UNIVERSITY HOSPITALS OF NORTH MIDLANDS NHS TRUST   (United Kingdom)

Author keywords

GLP 1 agonist; Retinopathy; Screening

Indexed keywords

EXENDIN 4; GLUCAGON LIKE PEPTIDE 1; HEMOGLOBIN A1C; INSULIN; LIRAGLUTIDE;

ADULT; AGED; ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DIABETIC RETINOPATHY; DISEASE COURSE; DISEASE DURATION; FEMALE; GLYCEMIC CONTROL; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREGNANCY; RETROSPECTIVE STUDY; SCREENING TEST;

ADULT; AGED; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; GLUCAGON-LIKE PEPTIDE 1; HUMANS; INSULIN INFUSION SYSTEMS; MALE; MASS SCREENING; MIDDLE AGED; PREGNANCY; PREGNANCY IN DIABETICS; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 82955187978     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2011.08.017     Document Type: Article

References (16)

1. Heine R.J., Van Gaal L.F., Johns D., Mihm M.J., Widel M.H., Brodows R.G., et al. Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes: a randomized trial. Ann Intern Med 2005, 143(8):559-569.
2. Varanasi A., Chaudhuri A., Dhindsa S., Arora A., Lohano T., Vora M., et al. Durability of effects of exenatide treatment on glycaemic control, body weight, systolic blood pressure, Crp and triglyceride concentrations. Endocr Pract 2010, 1-20.
3. Vestgaard M., Ringholm L., Laugesen C.S., Rasmussen K.L., Damm P., Mathiesen E.R. Pregnancy-induced sight-threatening diabetic retinopathy in women with type 1 diabetes. Diabet Med 2010, 27(4):431-435.
4. Dahl-Jorgensen K., Brinchmann-Hansen O., Hanssen K.F., Sandvik L., Aagenaes O. Rapid tightening of blood glucose control leads to transient deterioration of retinopathy in insulin dependent diabetes mellitus: the Oslo study. Br Med J (Clin Res Ed) 1985, 290(6471):811-815.
5. Rasmussen K.L., Laugesen C.S., Ringholm L., Vestgaard M., Damm P., Mathiesen E.R. Progression of diabetic retinopathy during pregnancy in women with type 2 diabetes. Diabetologia 2010, 53(6):1076-1083.
6. Henricsson M., Nilsson A., Janzon L., Groop L. The effect of glycaemic control and the introduction of insulin therapy on retinopathy in non-insulin-dependent diabetes mellitus. Diabet Med 1997, 14(2):123-131.
7. van Ballegooie E., Hooymans J.M., Timmerman Z., Reitsma W.D., Sluiter W.J., Schweitzer N.M., et al. Rapid deterioration of diabetic retinopathy during treatment with continuous subcutaneous insulin infusion. Diabetes Care 1984, 7(3):236-242.
8. Brooks A.M., Lissett C.A. A dramatic deterioration in diabetic retinopathy with improvement in glycated haemoglobin (HbA(1c)) on exenatide treatment. Diabet Med 2009, 26(2):190.
9. Chantelau E. Evidence that upregulation of serum IGF-1 concentration can trigger acceleration of diabetic retinopathy. Br J Ophthalmol 1998, 82(7):725-730.
10. Grunwald J.E., Riva C.E., Martin D.B., Quint A.R., Epstein P.A. Effect of an insulin-induced decrease in blood glucose on the human diabetic retinal circulation. Ophthalmology 1987, 94(12):1614-1620.
11. Henricsson M., Berntorp K., Fernlund P., Sundkvist G. Progression of retinopathy in insulin-treated type 2 diabetic patients. Diabetes Care 2002, 25(2):381-385.
12. Nagi D.K., Gosden C., Walton C., Winocour P.H., Turner B., Williams R., et al. A national survey of the current state of screening services for diabetic retinopathy: ABCD-diabetes UK survey of specialist diabetes services 2006. Diabet Med 2009, 26(12):1301-1305.
13. National Institute for Health and Clinical Excellence. Type 2 Diabetes: Newer Agents: National Institute for Health and Clinical Excellence (NICE); 2009.
14. Lauritzen T., Frost-Larsen K., Larsen H.W., Deckert T. Two-year experience with continuous subcutaneous insulin infusion in relation to retinopathy and neuropathy. Diabetes 1985, 34(Suppl. 3):74-79.
15. Reichard P., Britz A., Cars I., Nilsson B.Y., Sobocinsky-Olsson B., Rosenqvist U. The Stockholm Diabetes Intervention Study (SDIS): 18 months' results. Acta Med Scand 1988, 224(2):115-122.
16. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med, 1993;329(14):977-986.